Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Aivf Ltd.’s profile is in Biotechnology & Pharmaceuticals and shows 1 pending office action. The record identifies 1 distinct examiner and 1 distinct art unit. HAYES, JONATHAN EDWARD is the busiest examiner, with 1 pending matter assigned to that examiner. These figures indicate that the recorded prosecution activity is concentrated in one biotechnology and pharmaceutical examination path.
For practitioners, the immediate task is to address the pending action with a response tailored to that examiner’s position and the assigned art unit. The narrow assignment structure supports a consistent claim and amendment strategy across the matter. Counsel can use the application’s existing record as the principal source for anticipating the next examination issue, rather than attempting to reconcile multiple examiner or art-unit approaches.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAYES, JONATHAN EDWARD | 1 | 37.0% | +24.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025214 | SYSTEM AND METHOD FOR REPRESENTING A BIOLOGICAL PROCESS VIA NON-SPEECH AUDIO | HAYES, JONATHAN EDWARD | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18025214 | SYSTEM AND METHOD FOR REPRESENTING A BIOLOGICAL PROCESS VIA NON-SPEECH AUDIO | HAYES, JONATHAN EDWARD | — |
| Art Unit | Apps |
|---|---|
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18025214 | SYSTEM AND METHOD FOR REPRESENTING A BIOLOGICAL PROCESS VIA NON-SPEECH AUDIO | HAYES, JONATHAN EDWARD | 1685 | §102§103§112 | Non-Final OA | — | Pending | Mar 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAivf Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Jonathan Edward Hayes has the most, with 1 of Aivf Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.